BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30167373)

  • 1. Quantification and visualization of lipid landscape in glioma using in -and opposed-phase imaging.
    Seow P; Narayanan V; Hernowo AT; Wong JHD; Ramli N
    Neuroimage Clin; 2018; 20():531-536. PubMed ID: 30167373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel application of chemical shift gradient echo in- and opposed-phase sequences in 3 T MRI for the detection of H-MRS visible lipids and grading of glioma.
    Ramli N; Khairy AM; Seow P; Tan LK; Wong JH; Ganesan D; Rahmat K
    Eur Radiol; 2016 Jul; 26(7):2019-29. PubMed ID: 26560718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid Fraction Derived From MRI In- and Opposed-Phase Sequence as a Novel Biomarker for Predicting Survival Outcome of Glioma.
    Seow P; Narayanan V; Romelean RJ; Wong JHD; Win MT; Chandran H; Chinna K; Rahmat K; Ramli N
    Acad Radiol; 2020 Feb; 27(2):180-187. PubMed ID: 31155487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
    Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
    J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glioma-grade diagnosis using in-phase and out-of-phase T1-weighted magnetic resonance imaging: A prospective study.
    De Pardieu M; Boucebci S; Herpe G; Fauche C; Velasco S; Ingrand P; Tasu JP
    Diagn Interv Imaging; 2020; 101(7-8):451-456. PubMed ID: 32446598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of tissue heterogeneity using diffusion tensor and diffusion kurtosis imaging for grading gliomas.
    Raja R; Sinha N; Saini J; Mahadevan A; Rao KN; Swaminathan A
    Neuroradiology; 2016 Dec; 58(12):1217-1231. PubMed ID: 27796448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioma grading using a machine-learning framework based on optimized features obtained from T
    Sengupta A; Ramaniharan AK; Gupta RK; Agarwal S; Singh A
    J Magn Reson Imaging; 2019 Oct; 50(4):1295-1306. PubMed ID: 30895704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
    Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
    Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
    J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive electrical conductivity measurement by MRI: a test of its validity and the electrical conductivity characteristics of glioma.
    Tha KK; Katscher U; Yamaguchi S; Stehning C; Terasaka S; Fujima N; Kudo K; Kazumata K; Yamamoto T; Van Cauteren M; Shirato H
    Eur Radiol; 2018 Jan; 28(1):348-355. PubMed ID: 28698943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR Imaging-derived Oxygen Metabolism and Neovascularization Characterization for Grading and IDH Gene Mutation Detection of Gliomas.
    Stadlbauer A; Zimmermann M; Kitzwögerer M; Oberndorfer S; Rössler K; Dörfler A; Buchfelder M; Heinz G
    Radiology; 2017 Jun; 283(3):799-809. PubMed ID: 27982759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amide proton transfer imaging to discriminate between low- and high-grade gliomas: added value to apparent diffusion coefficient and relative cerebral blood volume.
    Choi YS; Ahn SS; Lee SK; Chang JH; Kang SG; Kim SH; Zhou J
    Eur Radiol; 2017 Aug; 27(8):3181-3189. PubMed ID: 28116517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance spectroscopy detection of high lipid levels in intraaxial tumors without central necrosis: a characteristic of malignant lymphoma.
    Yamasaki F; Takayasu T; Nosaka R; Amatya VJ; Doskaliyev A; Akiyama Y; Tominaga A; Takeshima Y; Sugiyama K; Kurisu K
    J Neurosurg; 2015 Jun; 122(6):1370-9. PubMed ID: 25748300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating feasibility of high resolution T1-perfusion MRI with whole brain coverage using compressed SENSE: Application to glioma grading.
    Sasi S D; Ramaniharan AK; Bhattacharjee R; Gupta RK; Saha I; Van Cauteren M; Shah T; Gopalakrishnan K; Gupta A; Singh A
    Eur J Radiol; 2020 Aug; 129():109049. PubMed ID: 32464580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomics strategy for glioma grading using texture features from multiparametric MRI.
    Tian Q; Yan LF; Zhang X; Zhang X; Hu YC; Han Y; Liu ZC; Nan HY; Sun Q; Sun YZ; Yang Y; Yu Y; Zhang J; Hu B; Xiao G; Chen P; Tian S; Xu J; Wang W; Cui GB
    J Magn Reson Imaging; 2018 Dec; 48(6):1518-1528. PubMed ID: 29573085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative grading of supratentorial gliomas using high or standard b-value diffusion-weighted MR imaging at 3T.
    Cihangiroglu MM; Ozturk-Isik E; Firat Z; Kilickesmez O; Ulug AM; Ture U
    Diagn Interv Imaging; 2017 Mar; 98(3):261-268. PubMed ID: 28038915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of grade II/III and grade IV glioma by combining "T1 contrast-enhanced brain perfusion imaging" and susceptibility-weighted quantitative imaging.
    Saini J; Gupta PK; Sahoo P; Singh A; Patir R; Ahlawat S; Beniwal M; Thennarasu K; Santosh V; Gupta RK
    Neuroradiology; 2018 Jan; 60(1):43-50. PubMed ID: 29090331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Glioma Grading With Inflow-Based Vascular-Space-Occupancy MRI: A Preliminary Study at 3T.
    Li X; Liao S; Hua J; Guo L; Wang D; Xiao X; Zhou J; Liu X; Tan Y; Lu L; Xu Y; Wu Y
    J Magn Reson Imaging; 2019 Dec; 50(6):1817-1823. PubMed ID: 30932289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biopsy targeting with dynamic contrast-enhanced versus standard neuronavigation MRI in glioma: a prospective double-blinded evaluation of selection benefits.
    Keil VC; Pintea B; Gielen GH; Greschus S; Fimmers R; Gieseke J; Simon M; Schild HH; Hadizadeh DR
    J Neurooncol; 2017 May; 133(1):155-163. PubMed ID: 28425048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.
    Jiang S; Eberhart CG; Zhang Y; Heo HY; Wen Z; Blair L; Qin H; Lim M; Quinones-Hinojosa A; Weingart JD; Barker PB; Pomper MG; Laterra J; van Zijl PCM; Blakeley JO; Zhou J
    Eur J Cancer; 2017 Sep; 83():9-18. PubMed ID: 28704644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.